Tag Archives: RSV

RSV prevention, fewer jabs for babies?

With all the hype regarding COVID-19 and a vaccine that may or may not be coming soon, we can use the story of RSV as an object lesson. Why do we give passive immunization to preterm infants against RSV rather … Continue reading

Posted in Neonatal Research | Tagged , | 3 Comments

Palivizumab for late preterm infants, can we afford it?

It is quite clear that palivizumab reduces the incidence of RSV disease, and probably also the severity, among those who still get it nevertheless. It is just as clear that it is extremely expensive. If RSV is likely to make … Continue reading

Posted in Neonatal Research | Tagged , , | 6 Comments